CJC-1295 (No DAC) + Ipamorelin Blend
| Attribute | Detail |
|---|---|
| Catalog No. | [Insert Product Number Here] |
| Purity | >98% (Third-Party Tested HPLC/MS) |
| Form | Lyophilized Powder |
| Quantity | 5mg CJC-1295 (MOD GRF 1-29) + 5mg Ipamorelin |
| Blend Ratio | 1:1 Ratio (Total 10mg) |
⚠️ FOR LABORATORY RESEARCH USE ONLY ⚠️
This product is a research chemical blend intended strictly for in vitro and ex vivo laboratory experimentation. It is explicitly labeled "Not For Human Consumption."
Product Description
This research blend combines two potent, highly specific growth hormone secretagogues (GHS) for synergistic studies in laboratory settings.
CJC-1295 (No DAC) / MOD GRF 1-29 is a synthetic GHRH analogue that stimulates the natural, pulsatile release of endogenous growth hormone (GH) from the pituitary gland.
Ipamorelin is a selective ghrelin mimetic (pentapeptide) that also stimulates GH release but acts through the GHS receptor. It is noted in research for avoiding significant release of other hormones like cortisol or prolactin.
Scientific Research Applications
Combining these two peptides allows researchers to investigate a synergistic approach to stimulating growth hormone dynamics in experimental models. When used together, they act on different pathways (GHRH receptor and GHS receptor) to produce a potentially amplified effect on GH release.
Key research areas for this blend include:
- Synergistic GH Release: Researchers study the combined effect of these peptides on the pituitary gland, which appears to maximize GH secretion in animal models beyond what either peptide achieves alone.
- Endocrine Function Studies: Investigations focus on the mechanisms of simultaneous GHRH and GHS receptor activation and their downstream impact on IGF-1 levels and metabolic markers in lab subjects.
- Body Composition Research: Studies in animal models explore how enhanced, naturalistic GH release affects muscle development, fat metabolism, and bone density within a controlled research environment.
Technical Specifications
| Component | Sequence | Molecular Formula |
|---|---|---|
| MOD GRF 1-29 | Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂ | C152H252N44O42S |
| Ipamorelin | Aib-His-D-2-Nal-D-Phe-Lys-NH₂ | C38H49N9O5 |
- Storage: Store lyophilized powder at 2°C - 8°C. Upon reconstitution, store at 2°C - 8°C and use within the recommended timeframe for research integrity. Protect from light.
Important Regulatory & Safety Information
- Unapproved Drugs: Both Ipamorelin and MOD GRF 1-29 are research chemicals and unapproved drugs. They are not intended to diagnose, treat, cure, or prevent any disease.
- No Human Use Data: There is a lack of comprehensive human clinical safety data for this specific research chemical formulation/blend. Their safety and efficacy in humans have not been established.
- Prohibited in Sports: Both components are prohibited substances under the World Anti-Doping Agency (WADA) Prohibited List.
- Purchaser Responsibility: By purchasing this product, the buyer acknowledges they are a qualified researcher and assumes all liability for the use and handling of this research chemical blend. You must comply with all applicable laws and regulations in your jurisdiction.
